NCT07443982 (AMI-HOPE) is a NA clinical trial of Standard of Care (SOC) in Acute Myocardial Infarction (AMI), sponsored by National University Heart Centre, Singapore.

Who is sponsoring NCT07443982?

NCT07443982 is sponsored by National University Heart Centre, Singapore.

What drugs are being tested in NCT07443982?

Interventions in NCT07443982: Standard of Care (SOC), Pharmacist-led digital platform assisted care.

What condition does NCT07443982 study?

NCT07443982 studies Acute Myocardial Infarction (AMI).

Is NCT07443982 still recruiting?

NCT07443982 is currently active, enrolled. Last updated 2 March 2026.

Last reviewed 2026-03-02 · How we verify

NCT07443982: AMI-HOPE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acute Myocardial Infarction - Allied Health-Oriented Patient-centered Digitally-Enabled Care

Active, enrolled NA Last updated 2 March 2026

What this trial tests

NA trial testing Standard of Care (SOC) in Acute Myocardial Infarction (AMI) in 1,633 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

11 January 2023

Primary endpoint
30 September 2026

30 September 2026

Quick facts

Lead sponsor	National University Heart Centre, Singapore
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	1,633
Start date	11 January 2023
Primary completion	30 September 2026
Estimated completion	30 September 2026
Sites	6 locations across Singapore

Drugs / interventions tested

Standard of Care (SOC) — full drug profile →
Pharmacist-led digital platform assisted care

Conditions studied

Acute Myocardial Infarction (AMI) — all drugs for Acute Myocardial Infarction (AMI) →

Sponsor

National University Heart Centre, Singapore

Who can join

Adults 21 to 90, any sex, with Acute Myocardial Infarction (AMI). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Acute Myocardial Infarction - allied Health Oriented, Patient centered, and digitally Enabled care (AMI-HOPE) program is a model of care designed to improve post-AMI well-being, safety, and outcomes through greater involvement of AHPs in patient care and integrating digital technologies into routine primary care disease management. AMI-HOPE aims to deliver solutions to these identified gaps of care which will transform healthcare planning both at cluster and national levels. The cornerstone of the AMI-HOPE program will be upskilling pharmacists to take on low-intermediate complexity clinician roles during the post-discharge period. The first 6 months will be anchored by tertiary care before a handoff to primary care. This frees up cardiologists to focus on high complexity cases.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Standard of Care (SOC)

Trials testing the same drug.

NCT07415577 — The Use of Cultured (Dermal) Epithelial Autografts in Severely Burned Patients · not yet recruiting
NCT07329946 — Immuno-inflammatory Response of Erdosteine in COPD · NA · not yet recruiting
NCT07461961 — CORTISHOCK-P: Trial of Corticosteroids in Inflammation-Enriched Heart Failure Cardiogenic Shock · Phase 2 · not yet recruiting
NCT07227909 — NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy · Phase 2 · not yet recruiting
NCT07379684 — A Study of Amicidin-β Topical Solution for Patients With Surgical or Traumatic Wound Infections · Phase 1 · recruiting

Other recruiting trials for Acute Myocardial Infarction (AMI)

Currently open trials in the same condition.

NCT07400601 — A Clinical Cohort Registry Study on Primary PCI for Acute Myocardial Infarction at Zhongshan Hospital · recruiting
NCT07208006 — Very Early PCSK9 Inhibition for Acute Myocardial Infarction · NA · recruiting
NCT07537296 — Coronary and Myocardial Evaluation by Cardiac CT for Acute Myocardial Infarction · recruiting
NCT07276282 — Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction · Phase 3 · recruiting
NCT07293923 — Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock · NA · recruiting

Other National University Heart Centre, Singapore trials

Trials by the same sponsor.

NCT04601467 — PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE · Phase 2 · terminated
NCT02483494 — Effectiveness of Advanced Practice Nurse-Led Telehealth on Readmissions · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07443982 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National University Heart Centre, Singapore
Last refreshed: 2 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07443982.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing